FDA Adverse Event Malfunction Summary report: N

ICON 25 HCG (COMBO CASSETTE)

MDR report key: 2123345 · Received June 10, 2011

Report

Report Number
2027969-2011-01301
Event Type
Malfunction
Date Received
June 10, 2011
Date of Event
May 18, 2011
Report Date
June 10, 2011
Manufacturer
ALERE SAN DIEGO, INC.
Product Code
JHI
PMA / PMN Number
K993065
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATION: CONTROL: 25MIU/ML HCG URINE CONTROL LOT: HCG110105-01, 100MIU/ML HCG URINE CONTROL LOT: HCG110307-01, 278.9IU/ML HCG URINE CONTROL LOT: HCG110124-01. SUMMARY OF RESULTS: THE RETENTION DEVICES MEET QC SPECIFICATION, DETAILS AS BELOW: CORRECT POSITIVE RESULTS WERE OBSERVED WHEN TESTED WITH 25MIU/ML HCG URINE CONTROL AT 3 MIN READ TIME (N=4). THE 100MIU/ML HCG URINE CONTROL YIELDED CLEARLY POSITIVE RESULTS AT 3 MIN READ TIME (N=3). THE 278.9IU/ML HCG URINE CONTROL YIELDED CLEARLY POSITIVE RESULTS AT 3 MIN READ TIME (N=3). CONCLUSION: FROM RETAIN TESTING WITH IN-HOUSE CONTROLS, THE CLIENT'S RESULT WAS NOT REPLICATED AND THE PRODUCT PERFORMED AS EXPECTED MEETING QC SPECIFICATIONS. VERIFIED THE PRODUCT NUMBER, PRODUCT DESCRIPTION, LOT NUMBER AND BATCH RECORD; NO ABNORMAL RESULTS WERE FOUND. NO CORRECTIVE ACTION REQUIRED AT THIS TIME AS NO PRODUCT DEFICIENCY WAS ESTABLISHED.

Description of Event or Problem · 1

CALLER REPORTED THREE INSTANCES OF POTENTIAL FALSE NEGATIVE URINE HCG RESULTS VS. SERUM QUANTITATIVE RESULTS. IN THE LAST WEEK OR SO, THE CUSTOMER HAD THREE INSTANCES WHERE THEY WERE GETTING NEGATIVE TEST RESULTS ON PT URINE SAMPLES WHILE THE SERUM QUANTITATIVE RESULTS WERE FROM 49 TO 200,000MIU/ML. THE THIRD INSTANCE OCCURRED TODAY ((B)(6) 2011) WHERE THE URINE HCG RESULT WAS NEGATIVE AND THE SERUM QUANTITATIVE VALUE WAS 72,000MIU/ML.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ICON 25 HCG (COMBO CASSETTE) HCG PREGNANCY TEST JHI ALERE SAN DIEGO, INC. FHC-202 HCG0120539

Patients

Seq Age Sex Outcome Treatment
1